Alvotech

ALVONasdaq Luxembourg Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$2.280 B

$5.84 -0.68%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

312,021,375

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Alvotech lists more than one class of stock. Company figures above cover all classes combined.

ALVOW

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#27Denali TherapeuticsDNLI$3.45B
#28Beam TherapeuticsBEAM$2.68B
#29AlvotechALVO$2.28B
#30Biocryst PharmaceuticalsBCRX$2.24B
#31Adma BiologicsADMA$2.20B

What if Alvotech were worth as much as…

Open the what-if tool →

Gold $30.2T

$77,437.33

Per share 13,260× higher

Bitcoin $1.74T

$4,460.85

Per share 764× higher

Nvidia $5.52T

$14,127.36

Per share 2,419× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Alvotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.